Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00459693 · ClinicalTrials.gov registry record · NA
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
A NA study, sponsored by National Institute of Mental Health (NIMH).
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00459693 is a NA study that was terminated before completion, run by National Institute of Mental Health (NIMH). The registered enrollment target is 40 participants.
The verdict
NCT00459693, a NA study, was terminated before completion, sponsored by National Institute of Mental Health (NIMH).
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this protocol is to measure a receptor in the brain using positron emission tomography (PET) that is involved in inflammation.
Interventions
- DRUG [11C]PBR28
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-04-09 |
| Est. Completion | 2014-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00459693
The ClinicalTrials.gov registry entry for NCT00459693 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [11C]PBR28 is the first listed.
NCT00459693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00459693 about?
NCT00459693 is a clinical study titled "PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)". The purpose of this protocol is to measure a receptor in the brain using positron emission tomography (PET) that is involved in inflammation.
What is the current status of trial NCT00459693?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2007-04-09. Estimated completion is 2014-04-06.
What interventions are being tested in trial NCT00459693?
The interventions under investigation include: [11C]PBR28 (DRUG).
Who is sponsoring clinical trial NCT00459693?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.